Clinical Trials Logo

Clinical Trial Summary

Er:YAG ablative fractional laser-assisted photodynamic therapy (AFL-PDT) has shown significant benefit for the treatment of actinic keratosis(AK). Er:YAG ablative fractional laser ablates the epidermis and dermis without significant thermal injury, creating microscopic ablation zones (MAZ) in the portion of the skin that the laser is applied to. The formed MAZ depends on the laser parameters such as laser depth, laser density and laser passes, which affect the treatment outcome.


Clinical Trial Description

The investigators aimed to investigate whether the use of increased laser ablative depth affects the efficacy, side effects, cosmetic outcomes, and PPIX accumulation of AFL-PDT for facial AK in a randomized clinical trial. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03325803
Study type Interventional
Source Dong-A University
Contact
Status Completed
Phase Phase 1
Start date September 1, 2015
Completion date September 20, 2017

See also
  Status Clinical Trial Phase
Completed NCT02976727 - Efficacy of Topical Calcipotriol-assisted AFL-PDT in Actinic Keratosis Phase 1